Stoke Therapeutics (STOK) Return on Sales (2022 - 2025)
Historic Return on Sales for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to 3.61%.
- Stoke Therapeutics' Return on Sales rose 17900.0% to 3.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year increase of 65000.0%. This contributed to the annual value of 2.43% for FY2024, which is 95200.0% up from last year.
- Per Stoke Therapeutics' latest filing, its Return on Sales stood at 3.61% for Q3 2025, which was up 17900.0% from 1.7% recorded in Q2 2025.
- Over the past 5 years, Stoke Therapeutics' Return on Sales peaked at 0.71% during Q1 2025, and registered a low of 12.37% during Q2 2023.
- For the 4-year period, Stoke Therapeutics' Return on Sales averaged around 5.91%, with its median value being 6.26% (2024).
- In the last 5 years, Stoke Therapeutics' Return on Sales plummeted by -47300bps in 2023 and then surged by 91600bps in 2024.
- Stoke Therapeutics' Return on Sales (Quarter) stood at 7.86% in 2022, then dropped by -23bps to 9.64% in 2023, then soared by 95bps to 0.47% in 2024, then tumbled by -663bps to 3.61% in 2025.
- Its Return on Sales stands at 3.61% for Q3 2025, versus 1.7% for Q2 2025 and 0.71% for Q1 2025.